Showing 1 posts of 1 posts found.
Biotech company Amgen has abandoned its late-stage trial of a new drug for one of the most hard-to-treat of all …
Scots neonatal innovations target hearing loss and earlier care
FDA grants De Novo authorisation to light-filtering device for migraine
Southgate opens Innovation Lab for logistics and fulfilment development
Bioptimus partners with Cancer Research Horizons to expand AI cancer data set
Agentis Health Group acquires Clinical Pharmacist Solutions